Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients.

To identify early metabolic abnormalities in type 2 diabetes mellitus, we measured insulin secretion, sensitivity to insulin, and hepatic insulin extraction in 48 healthy normal glucose-tolerant Brazilians, first-degree relatives of type 2 diabetic patients (FH+). Each individual was matched for sex, age, weight, and body fat distribution with a person without history of type 2 diabetes (FH-). Both groups were submitted to a hyperglycemic clamp procedure (180 mg/dl). Insulin release was evaluated in its two phases. The first was calculated as the sum of plasma insulin at 2.5, 5.0, 7.5, and 10.0 min after the beginning of glucose infusion, and the second as the mean plasma insulin level in the third hour of the clamp procedure. Insulin sensitivity index (ISI) was the mean glucose infusion rate in the third hour of the clamp experiment divided by the mean plasma insulin concentration during the same period of time. Hepatic insulin extraction was determined under fasting conditions and in the third hour of the clamp procedure as the ratio between C-peptide and plasma insulin levels. FH+ individuals did not differ from FH- individuals in terms of the following parameters [median (range)]: a) first-phase insulin secretion, 174 (116-221) vs 207 (108-277) microU/ml, b) second-phase insulin secretion, 64 (41-86) vs 53 (37-83) microU/ml, and c) ISI, 14.8 (9.0-20.8) vs 16.8 (9.0-27.0) mg kg-1 min-1/ microU ml-1. Hepatic insulin extraction in FH+ subjects was similar to that of FH- ones at basal conditions (median, 0.27 vs 0.27 ng/microU) and during glucose infusion (0.15 vs 0.15 ng/ micro U). Normal glucose-tolerant Brazilian FH+ individuals well-matched with FH- ones did not show defects of insulin secretion, insulin sensitivity, or hepatic insulin extraction as tested by hyperglycemic clamp procedures.

[1]  R. Gleason,et al.  Abnormal serum growth hormone responses in genetically potential-diabetic male patients with normal oral glucose tolerance: Evidence for an insulin-like action of growth hormone in vivo , 1973, Diabetologia.

[2]  M. Serrano-Ríos,et al.  Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics , 1970, Diabetologia.

[3]  H. Yki-Järvinen Role of insulin resistance in the pathogenesis of NIDDM , 1995, Diabetologia.

[4]  K. Liestøl,et al.  Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. , 2000, Diabetes care.

[5]  K. Liestøl,et al.  Type 2 Diabetes and Maternal Family History , 2000 .

[6]  P. Poulsen,et al.  Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study , 1999, Diabetologia.

[7]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[8]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[9]  J. Gerich,et al.  The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. , 1998, Endocrine reviews.

[10]  D. Erkelens,et al.  Insulin Secretion in Normal Glucose-Tolerant Relatives of Type 2 Diabetic Subjects: Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests , 1998, Diabetes Care.

[11]  M. Walker,et al.  Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families , 1997, Diabetologia.

[12]  M. Byrne,et al.  Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function. , 1996, The American journal of physiology.

[13]  R. Torella,et al.  Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin. , 1995, Metabolism: clinical and experimental.

[14]  G. Dailey,et al.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.

[15]  K. Polonsky The β-Cell in Diabetes: From Molecular Genetics to Clinical Research , 1995, Diabetes.

[16]  A. Vaag,et al.  Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[17]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[18]  Geoffrey R. Norman,et al.  Biostatistics: The Bare Essentials , 1993 .

[19]  M. Rewers,et al.  Global Estimates for Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Adults , 1993, Diabetes Care.

[20]  R. DeFronzo,et al.  The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents , 1992, Diabetes.

[21]  R. Hamman Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). , 1992, Diabetes/metabolism reviews.

[22]  L. Franco,et al.  Multicenter Study of the Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in the Urban Brazilian Population Aged 30–69 yr , 1992, Diabetes Care.

[23]  T. Jenssen,et al.  Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. , 1992, The Journal of clinical endocrinology and metabolism.

[24]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[25]  R. DeFronzo,et al.  The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.

[26]  H. Yki-Järvinen Glucose toxicity. , 1992, Endocrine reviews.

[27]  K. Osei,et al.  Insulin Sensitivity, Glucose Effectiveness, and Body Fat Distribution Pattern in Nondiabetic Offspring of Patients With NIDDM , 1991, Diabetes Care.

[28]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[29]  J. Gerich,et al.  Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. , 1990, The Journal of clinical endocrinology and metabolism.

[30]  D. Porte,et al.  Islet Function and Insulin Sensitivity in the Non‐diabetic Offspring of Conjugal Type 2 Diabetic Patients , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[31]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[32]  H. King,et al.  Trends in the prevalence and incidence of diabetes: non-insulin-dependent diabetes mellitus. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[33]  V. Beral,et al.  REPRODUCTIVE HISTORIES IN DIABETIC WOMEN WITH LATER DEVELOPING FURTHER ENDOCRINE DISEASE , 1984, The Lancet.

[34]  P. Savage,et al.  C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. , 1979, The Journal of clinical endocrinology and metabolism.

[35]  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. , 1979, Diabetes.

[36]  P. Gorden,et al.  Unexplained Hyperinsulinemia in Normal and “Prediabetic” Pima Indians Compared with Normal Caucasians: An Example of Racial Differences in Insulin Secretion , 1977, Diabetes.

[37]  P. Savage,et al.  INSULIN RESPONSES TO ORAL CARBOHYDRATE IN TRUE PREDIABETICS AND MATCHED CONTROLS , 1975, The Lancet.

[38]  D. Pyke,et al.  Glucose Tolerance and Serum Insulin in Identical Twins of Diabetics , 1970, British medical journal.

[39]  E. Lowrie,et al.  Glucose metabolism and insulin secretion in uremic, prediabetic, and normal subjects. , 1970, The Journal of laboratory and clinical medicine.

[40]  G. Grodsky,et al.  Early Phase of Insulin Release , 1968, Diabetes.

[41]  R. Gleason,et al.  Diminished Serum Insulin Response to Glucose in Genetic Prediabetic Males with Normal Glucose Tolerance , 1968, Diabetes.

[42]  D. Pyke,et al.  Glucose tolerance and serum insulin in unaffected identcal twins of diabetics. , 1967, British medical journal.

[43]  J. Colwell,et al.  Diminished Insulin Response to Hyperglycemia in Prediabetes and Diabetes , 1967, Diabetes.

[44]  L. Stimmler SERUM-INSULIN RESPONSE TO GLUCOSE IN PREDIABETIC SUBJECTS. , 1965, Lancet.

[45]  W. Shee,et al.  Part-time nursing. , 1947, Lancet.